Dumb Retail Investors to Smart Institutional investors :: for this API to FDF to CDMO to Biotechnology synthesis
धीरे धीरे से मेरी company में आना 🎵🎶
धीरे धीरे से share को उठना 🎻
......
......
तुमने wait किया है इतना जानेजाना
More from Sajal Kapoor
Many stock specific questions on my DM or otherwise remain unanswered. Have shared my thesis, process/framework over many months and would encourage you all to find your own process that suits your very own genome. Learn to do that hard leg-work. Put that effort. Survive. Thrive.
[Free CDMO Masterclass #18] https://t.co/208eQbYKEF
— Conviction | Patience (@unseenvalue) July 25, 2021
[Free Art of Investing] https://t.co/bHvUqnpiTE
[Paid IIC Dec 2020 on SeQuent] https://t.co/3iDO438Et9
[Charity fund raise on Unseen Trends in Biotechnology] https://t.co/eNi1x1qwhH
[Q&A on APIs] https://t.co/EQGz007a9S
Affordable and Accessible research and innovation in an unseen olympics where many Indian companies win 🥇 and make the country proud. US enterprises are way ahead in cutting-edge Lab R&D, but they come to 🇮🇳 for scale-up and affordable manufacturing (CDMO model).
Go 🇮🇳 Go 👏👏
Go 🇮🇳 Go 👏👏
Watch the journey of\xa0Insulin Glargine's landmark USFDA approval for first interchangeable #biosimilar for the treatment of diabetes, a testament to #BioconBiologics' scientific excellence & robust quality comparibility data. https://t.co/JSM4LPqYdh
— Biocon (@Bioconlimited) August 1, 2021
More from Lauruslabs
Laurus Labs - Understand the concept of Breakaway Gap. https://t.co/zsDyFsYym4

Breakaway Gaps/Breakout Gaps.
— The_Chartist \U0001f4c8 (@nison_steve) October 2, 2021
Attached tweet of clerx for March 30th. See the chart to look for if the gap was filled or not? and, if price pulled back? https://t.co/AbjWWw1985 pic.twitter.com/zpHMcVaDJ7